Vergenix™SW is intended for the management of Surgical Wounds.
Vergenix™SW is based on our Vergenix™FG wound filler combined with an antimicrobial agent. Like Vergenix™FG, Vergenix™SW is wound matrix that provides a scaffold of pure human collagen which promotes wound closure through an engineered synchronization between scaffold degradation and growth of new tissue.
The combination of the Vergenix™SW with an antimicrobial agent is designed to help preventing bacterial contamination within the post-operative phase which is the main challenge to address in surgical wound management.
Note: Vergenix SW is under product development and is not approved for sale in Europe nor US